Journals / Diagnostic and Interventional Radiology / 2020 / Cilt: 26 - Sayı: 6

Hepatocellular carcinoma with macrovascular invasion: multimodality imaging features for the diagnosis

Pages
531–540
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Knowledge of the most common imaging features of HCC with macrovascular invasion may improve the diagnostic confidence of tumor thrombus in clinical practiceand help to guide patients’ management.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hepatocellular carcinoma (HCC) is frequently associated with macrovascular invasion of the portal vein or hepatic veins in advanced stages.
📊
Key Findings & Data:The accurate diagnosis of macrovascular invasionand the differentiation from bland non-tumoral thrombus has significant clinical and management implications, since it narrows the therapeutic options and it represents a mandatory contraindication for liver resection or transplantation.
💡
Conclusion & Impact:Knowledge of the most common imaging features of HCC with macrovascular invasion may improve the diagnostic confidence of tumor thrombus in clinical practiceand help to guide patients’ management.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Hepatocellular carcinoma (HCC) is frequently associated with macrovascular invasion of the portal vein or hepatic veins in advanced stages. The accurate diagnosis of macrovascular invasionand the differentiation from bland non-tumoral thrombus has significant clinical and management implications, since it narrows the therapeutic options and it represents a mandatory contraindication for liver resection or transplantation. The imaging diagnosis remains particularlychallenging since the imaging features of HCC with macrovascular invasion may be subtle, especially in lesions showing infiltrative appearance. However, each radiologic imaging modality mayprovide findings suggesting the presence of tumor thrombus rather than bland thrombus. Thepurpose of this paper is to review the current guidelines and imaging appearance of HCC withmacrovascular invasion. Knowledge of the most common imaging features of HCC with macrovascular invasion may improve the diagnostic confidence of tumor thrombus in clinical practiceand help to guide patients’ management.

🔖

Cite This Article

CANNELLA, R., TAIBBI, A., PORELLO, G., BURGIO, M. D., CABIBBO, G., BARTOLOTTA, T. V. (2020). Hepatocellular carcinoma with macrovascular invasion: multimodality imaging features for the diagnosis. Diagnostic and Interventional Radiology, Cilt: 26 - Sayı: 6, 531–540. https://ajindex.com/articles/349979

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015
  2. E359–386. [Crossref] 2. Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999
  3. 329–338. [Crossref] 3. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol 2018
  4. 182–236. 4. Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 2018
  5. 723–750. [Crossref] 5. Reynolds AR, Furlan A, Fetzer DT, et al. Infiltrative hepatocellular carcinoma: what radiologists need to know. Radiographics 2015
  6. 371–386. [Crossref] 6. Kneuertz PJ, Demirjian A, Firoozmand A, et al. Diffuse infiltrative hepatocellular carcinoma: assessment of presentation, treatment, and outcomes. Ann Surg Oncol 2012
  7. 2897– 2907. [Crossref] 7. American College of Radiology. CT/MRI Liver imaging reporting and data system v2018 Core. https://www.acr.org/Clinical-Resources/ Reporting-and-Data-Systems/LI-RADS/CT-MRILI-RADS-v2018. Accessed on October 2019. 8. Fraum TJ, Tsai R, Rohe E, et al. Differentiation of hepatocellular carcinoma from other hepatic malignancies in patients at risk: diagnostic performance of the Liver Imaging Reporting and Data System Version 2014. Radiology 2018
  8. 158–172. [Crossref] 9. Park SH, Lee SS, Yu E, et al. Combined hepatocellular-cholangiocarcinoma: Gadoxetic acid-enhanced MRI findings correlated with pathologic features and prognosis. J Magn Reson Imaging 2017
  9. 267–280. [Crossref] 10. Korean Liver Cancer Association
  10. National Cancer Center. 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Gut Liver 2019
  11. 227–299. [Crossref] 11. Elsayes KM, Kielar AZ, Chernyak V, et al. LIRADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance. J Hepatocel Carcinoma 2019
  12. 49–69. [Crossref] 12. Ludwig DR, Fraum TJ, Cannella R, et al. Hepatocellular carcinoma (HCC) versus non-HCC: accuracy and reliability of Liver Imaging Reporting and Data System v2018. Abdom Radiol 2019
  13. 2116–2132. [Crossref] 13. Danila M, Sporea I, Popescu A, Șirli R. Portal vein thrombosis in li